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Glycosaminogly~ans were anaiysed from skin fibroblasts with osteogenesis imperfecta (01) IIA and IIB. 
The content of sulphated glycosaminoglycans was greatly increased over age-matched controls and to a 
lesser extent with respect o older age control. Dermatan sulphate in comparison with older control was 
unaltered in the cells of 01 IIA and IIB. The concentration of heparan sulphate was higher in the cells 
than in the medium, whereas hyaluronic acid, chondroitin sulphate and dermatan sulphate content was 
higher in the medium. The level of hyaluronic acid was greatly elevated in the medium of 01 IIB with 
respect o both controls. 
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1. INTRODUCTION 
Osteogenesis imperfecta (01) is a genetically in- 
herited disorder of the connective tissues which has 
been subdivided into at least 5 types according to 
clinical and biochemical similarities [I]. At present 
the pathogenesis of this disease is not clearly un- 
derstood although ultrastructural [2,3] and bioche- 
mical [4,5] studies of this disorder in various tissu- 
es have been concerned with the analysis of the ex- 
tracellular matrix components like collagen, glyco- 
saminoglycans (GAGS) and glycoproteins [6,7]. 
These studies generally reflect an altered metabo- 
lism of one or more of the extracetlular matrix 
components, such as an alteration in the ratio of 
the type I to type III Collagen [8,9]. However, the 
studies on GAGS produced by cells in culture and 
tissues with different types of 01 have been incon- 
clusive, and both an increase and a decrease in 
their content has been reported [lo-121. Some of 
the changes in GAGS have been attributed to an 
altered metabolism of hyaluronic acid (HA), but 
very little is known of changes in 01 of the dif- 
ferent sulphated GAGS such as chondroitin sulph- 
ate (CS), heparan sulphate (HS) anq dermatan 
sulphate (DS). This study was undertaken on skin 
fibroblasts representing a rare but lethal form of 
01 (01 IIA and IIB) and our purpose was to exa- 
mine whether the metabolism of some or all of the 
different GAGS produced by these cells is altered 
in comparison with normal adult and foetal skin 
fibroblasts. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Normal human skin fibroblasts from newborn 
infants and foetuses, skin fibroblasts from foetu- 
ses with 01 IIA and IIB, were obtained from Dr 
D.W. Hollister and had been used in a previous 
study on collagen related to 01 [13]. These cells 
were plated in 25 cm’ falcon flasks at a density of 
1.5 x lo3 cells/cm*. The cells were cultured at 
37°C in Eagle’s Minimal Essential medium contai- 
ning 100 units/ml streptomycin-penicillin and 
100 mcg/ml kanamycin. After 3 days the culture 
medium was replaced by Eagle’s Minimal Essential 
medium containing 5 &i/ml [3H]glucosamine 
hydrochloride. 
2.2. Preparation of GAGS 
GAGS were isolated separately from the cells 
and their culture medium. The medium was decan- 
ted from the culture flasks and the cells detached 
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from the dish by incubation with 0.5 ml trypsin at 
37°C for 3-5 min. The cell suspension was then 
homogenized with a teflon homogenizer followed 
by digestion with papain [14], in the presence of 
0.5-l .O mg carrier chondroitin-4-sulphate. The di- 
gest was dialysed against distilled water and 
lyophilised. 
The medium was dialysed against distilled water 
and lyophilised. This sample was then digested 
with papain [14] in the presence of 0.5-1.0 mg 
chondroitin-4-sulphate followed by dialysis against 
water and lyophilisation. The lyophilised fractions 
of cells and medium were applied to columns 
(0.5 x 5 cm) of DEAE-sephacel in 1 ml water. The 
columns were eluted with 3 bed volumes each of 
0.02 M NaCl and 2.0 M NaCl. Majority of the la- 
belled GAGS were recovered in the 2.0 M NaCl 
eluate, which was lyophilised for further analysis. 
2.3. Electrophoresis 
Cellulose acetate electrophoresis of samples 
(10 ~1) was carried out in 0.1 M barium acetate 
(pH 5.0) at 4”C, as in [15] with the following modi- 
fications. The electrophoresis was performed at 
250 V for 30 min followed by immersion of the 
strip in 20% alcohol buffer (v/v) for 3 min. Subse- 
quently, the cellulose acetate strip was electropho- 
resed for a further 20 min at 250 V. The cellulose 
acetate strip was then cut into 1 mm wide sections, 
mixed with 5 ml of Rotizant scintillant and coun- 
ted in a Packard TriCarb 460C scintillation 
counter. 
3. RESULTS 
The cellulose acetate electrophoresis eparated a 
Fig. 1. The identification of different GAGS present in 
skin fibroblasts and their culture medium by cellulose 
acetate electrophoresis. The background counts have 
been subtracted from the results shown (see text for 
details). (a) GAG standards. The position to which HS 
migrates was determined by using a radiolabelled 
preparation of HS; (b) culture medium of newborn skin 
fibroblasts (control); (c) culture medium of foetal skin 
fibroblasts (control); (d) culture medium of fibroblasts 
with 01 type IIA; (e) culture medium of fibroblasts with 
01 type IIB; (f) newborn skin fibroblasts (control); (g) 
foetal skin fibroblasts (control); (h) fibroblasts with 01 
type IIA; (i) fibroblasts with 01 type IIB. 
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variety of GAGS from cells and their culture medi- 
um (fig.1). The total radioactivity incorporated in 
each GAG was compared directly with radioactivi- 
ty of the corresponding GAG in the controls. 
3.1. Controls 
The cells and medium of the foetal control con- 
tained a large amount of HA and negligible quanti- 
ties of the sulphated GAGS (table 1). The quantity 
of HA in the cells and medium of the newborn 
control was lower and the content of the sulphated 
GAGS higher in comparison with the foetal 
controls. 
3.2. OI cells 
The concentration of sulphated GAGS, with the 
exception of DS, showed small increases over the 
newborn control, whereas the content of HA was 
markedly elevated (table 1). In contrast, the level 
of all sulphated GAGS was greatly increased over 
the foetal control, particularly HS, which increa- 
sed in concentration by 5-6-fold. The rise in the 
content of HA was much smaller than the sulpha- 
ted GAGS with respect to the foetal control. 
The level of all GAGS, except DS, was slightly 
higher in 01 IIB than in 01 IIA. The content of HS 
was higher in the cells than in the medium, whereas 
HA, CS and DS were more concentrated in the me- 
dium (table 1). 
3.3. OI medium 
The concentration of HA was increased by 
about 3.4- and 13-fold in 01 IIA and IIB, respecti- 
vely, when compared with the newborn control. As 
with the cells, the content of sulphated GAGS was 
not much increased over this control. However, in 
comparison with the foetal control their content 
was greatly elevated, particularly CS, which was 
increased by about 6.4- and 7.3-fold in 01 IIA and 
IIB, respectively (table 1). The level of HA was 
3%fold higher in 01 IIB than in 01 IIA, but the 
content of the sulphated GAGS was not greatly al- 
tered between the two types of 01 studied (table 1). 
4. DISCUSSION 
Changes in the concentration of GAGS in skin 
fibroblasts cultured from patients with a lethal 
form of 01 were assessed. To eliminate biochemi- 
cal changes as a result of ageing, two controls of 
different stages of development were compared. 
Results showed differences in the content of 
GAGS between the controls chosen. The level of 
sulphated GAGS was higher and that of HA lower 
in the older cells (newborn control) than in the 
younger cells (foetal control). Such changes in the 
content of GAGS as a result of ageing are in good 
agreement with previous studies [ 161. 
The metabolism of GAGS in 01 cells and medi- 
Table 1 
The distribution of various GAGS in skin fibroblasts 
Sample 
Newborn controla 
Foetal controla 
01, IIA” 
01, IIBa 
cpm Ratios 
Newborn control/foetal control 
01, IIA/newborn control 
01, IIB/newborn control 
01, IIA/foetal control 
01, IIB/foetal control 
a cpm/106 cells 
HA 
370 
800 
1260 
4740 
0.46 
3.41 
12.81 
1.58 
5.93 
Medium 
DS HS 
70 50 
30 20 
110 70 
100 70 
2.33 2.50 
1.57 1.40 
1.43 1.40 
3.67 3.50 
3.33 3.50 
cs HA 
160 120 
40 325 
255 435 
290 53s 
4.00 0.37 
1.59 3.62 
1.81 4.46 
6.38 1.34 
1.25 1.65 
Cells 
DS HS cs 
70 80 120 
30 20 50 
70 95 165 
70 115 175 
2.33 4.00 2.40 
1.00 1.18 1.37 
1.00 1.44 1.46 
2.33 4.75 3.30 
2.33 5.75 3.50 
The values represented are averages of two determinations 
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urn was also markedly altered in comparison with 
the controls. The content of all GAGS was greatly 
elevated with respect to the foetal control, and as 
the 01 cells used in this study were similar in age 
to these control cells, the differences in GAGS bet- 
ween these cells therefore seem particularly impor- 
tant. In contrast, a large increase in HA and a 
smaller difference in the content of sulphated 
GAGS was observed with respect to the newborn 
control, however, such a comparison is important 
because it takes into account the differences in age 
of the cells and emphasizes the altered states of 
GAGS in skin fibroblasts with a lethal 01. 
The increases in the GAGS in cells and medium 
were variable. The content of HS was higher in the 
cells than in the medium, which may partly be ac- 
counted for by its association with cell membranes 
as previously demonstrated for a number of diffe- 
rent cell types [17,18]. However, HA, CS and DS 
are not retained at the cell membrane; hence their 
concentration in the medium is expected to be 
higher. 
In the type of 01 studied our results showed an 
overall increase in the content of GAGS was due to 
increases in sulphated and non-sulphated GAGS. 
Earlier studies on mixed populations of GAGS 
from skin fibroblasts with various forms of 01 
have revealed both an increase and decrease in 
their total content [l 1,19,20]. Such varied obser- 
vations may partly be due to the biochemical hete- 
rogeneity of this disorder which may be reflected 
by an altered metabolic capacity for these macro- 
molecules at various stages of 01 [20]. This view is 
further enhanced by similar ‘mixed’ findings on 
the content of GAGS in many tissues with dif- 
ferent types of 01 [11,12,21], although compari- 
sons in results between cells in culture and tissues 
must be made with some caution. 
At present there is no correlation between the 
sulphated GAGS and the severity of the disease. It 
is also not certain whether the increase in the con- 
tent of GAGS is a result of their increased synthe- 
sis or a reduced breakdown. However, the severity 
of the disease in lethal and milder forms of 01 in 
skin fibroblasts has been correlated with a large in- 
crease in HA concentration, which was paralleled 
with a rise in the HA synthetase activity 191. 
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